Cargando…
Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
Infections caused by vancomycin-resistant enterococci (VRE) may be difficult to treat because of the limited armamentarium of antimicrobial agents. The difficulty is compounded in pediatric patients in general and neonates in particular because many of the newer antimicrobials have not been studied...
Autores principales: | Beneri, Christy A, Nicolau, David P, Seiden, Howard S, Rubin, Lorry G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108720/ https://www.ncbi.nlm.nih.gov/pubmed/21694874 |
Ejemplares similares
-
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019) -
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
por: Chuang, Yu-Chung, et al.
Publicado: (2014) -
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
por: Fox, Emily, et al.
Publicado: (2022) -
622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
por: Simar, Shelby, et al.
Publicado: (2019) -
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
por: Peghin, Maddalena, et al.
Publicado: (2019)